Saturday, October 31, 2026
27.8 C
Bengaluru

Who Profits From Trust?

Indian healthcare does not suffer from a shortage of marketing. It suffers from a shortage of trustworthy information patients can use when decisions are urgent, expensive, and consequential.

MedicinMan’s latest Intelligence Report brings together issues that are usually discussed separately:

Pharma promotion. Hospital advertising. Cancer-drug pricing. Medical devices and consumables. Regulatory accountability. And healthcare trust itself.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

The paradox of the “Pharmacy of the World.” đź’Š

India has world-scale formulation capability, yet the chemistry beneath...

The Innovator’s Gene and the Generic’s Promise

A medicine must first be discovered. It must then...

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...

China’s Biopharma Strategy: A Warning and Opportunity for India

China is playing a long game in biopharma. And...

Topics

The paradox of the “Pharmacy of the World.” đź’Š

India has world-scale formulation capability, yet the chemistry beneath...

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...

Who Is Accountable for the Medicine in Your Hand?

The Accountability Gap: India’s Drug Regulatory System Your doctor prescribes...
spot_img

Related Articles

spot_imgspot_img